Glen Eagle Advisors’s Elevance Health ELV Stock Holding History

Glen Eagle Advisors’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.55K	Hold	4	–	–	﹤0.01%	932
2026 Q1	$1.17K	Hold	4	–	–	﹤0.01%	906
2025 Q4	$1.4K	Hold	4	–	–	﹤0.01%	925
2025 Q3	$1.29K	Hold	4	–	–	﹤0.01%	967
2025 Q2	$1.56K	Sell	4 -3	-43%	-$1.21K	﹤0.01%	873
2025 Q1	$3.06K	Hold	7	–	–	﹤0.01%	794
2024 Q4	$2.59K	Sell	7 -4	-36%	-$1.67K	﹤0.01%	840
2024 Q3	$5.73K	Hold	11	–	–	﹤0.01%	741
2024 Q2	$5.96K	Buy	11 +7	+175%	+$3.7K	﹤0.01%	737
2024 Q1	$2.07K	Hold	4	–	–	﹤0.01%	901
2023 Q4	$1.89K	Hold	4	–	–	﹤0.01%	869
2023 Q3	$1.74K	Hold	4	–	–	﹤0.01%	877
2023 Q2	$1.78K	Hold	4	–	–	﹤0.01%	886
2023 Q1	$1.84K	Buy	4 +2	+100%	+$952	﹤0.01%	865
2022 Q4	$1.03K	Buy	+2	New	+$1.01K	﹤0.01%	1014
2021 Q3	–	Sell	-27	Closed	-$10.3K	–	1068
2021 Q2	$10.3K	Hold	27	–	–	﹤0.01%	687
2021 Q1	$9.69K	Hold	27	–	–	﹤0.01%	674
2020 Q4	$8.67K	Hold	27	–	–	﹤0.01%	658
2020 Q3	$7.25K	Hold	27	–	–	﹤0.01%	647
2020 Q2	$7.1K	Hold	27	–	–	﹤0.01%	614
2020 Q1	$6.13K	Hold	27	–	–	﹤0.01%	591
2019 Q4	$8.15K	Hold	27	–	–	﹤0.01%	630
2019 Q3	$6.48K	Hold	27	–	–	﹤0.01%	589
2019 Q2	$7.62K	Buy	27 +17	+170%	+$4.64K	0.01%	545
2019 Q1	$2.87K	Buy	+10	New	+$2.89K	﹤0.01%	628
2018 Q4	–	Sell	-26	Closed	-$7.13K	–	728
2018 Q3	$7.13K	Buy	26 +9	+53%	+$2.34K	0.01%	512
2018 Q2	$4.05K	Buy	+17	New	+$3.94K	﹤0.01%	567

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Glen Eagle Advisors's ELV Position: Q2 2026 in Review

Glen Eagle Advisors held its Elevance Health (ELV) position steady in Q2 2026 at 4 shares worth $1.55K. The position accounts for ﹤0.01% of the portfolio, ranked #932.

Glen Eagle Advisors first reported a position in ELV in Q2 2018 and has held it in 27 quarters since. The position peaked at $10.3K in Q2 2021. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Glen Eagle Advisors held 4 shares of Elevance Health worth $1.55K as of Q2 2026.
Glen Eagle Advisors left its Elevance Health share count unchanged in Q2 2026.
Elevance Health made up ﹤0.01% of Glen Eagle Advisors's portfolio in Q2 2026, its #932 holding.
Glen Eagle Advisors first reported a position in Elevance Health in Q2 2018 and has held it in 27 quarters since.
Glen Eagle Advisors's Elevance Health position peaked at $10.3K in Q2 2021.
1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Glen Eagle Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.